Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
AYTU
AYTU
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
AYTU News
Aytu BioPharma Reports Q2 2026 Earnings with EXXUA Launch Insights
Feb 04 2026
seekingalpha
Aytu BioPharma AYTU Q2 2026 Earnings Transcript
Feb 03 2026
NASDAQ.COM
Aytu BioPharma Q2 Earnings Analysis
Feb 03 2026
seekingalpha
Aytu BioPharma to Announce Q2 Earnings on February 3rd
Feb 02 2026
seekingalpha
Healthcare Stocks with Strong Earnings Momentum Earn A+ EPS Revision Grades
Jan 16 2026
seekingalpha
Nutex Health Rises 21% in After-Hours Trading Following Revenue Increase; Biotech Competitors Also See Gains on Tuesday
Nov 19 2025
NASDAQ.COM
Aytu BioPharma Inc (AYTU) Q1 2026 Earnings Call Summary: Robust Performance of ADHD Portfolio
Nov 14 2025
Yahoo Finance
Applied Therapeutics, Omeros, and Others Experience Significant Price Changes After Market Close
Nov 14 2025
NASDAQ.COM
Maxim Group Reaffirms Buy Rating for Aytu BioPharma, Adjusts Price Target to $7
Sep 25 2025
Benzinga
Aytu announces EXXUA launch aimed at $22B MDD market and optimizes ADHD product lineup.
Sep 23 2025
SeekingAlpha
Biotech Stocks Rally in After-Hours Trading: Cassava, Helius, Werewolf, Aytu, and Equillium Drive Late Gains
Sep 23 2025
NASDAQ.COM
This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Jun 30 2025
Benzinga
Ascendiant Capital Initiates Coverage On Aytu BioPharma with Buy Rating, Announces Price Target of $12
Jun 30 2025
Benzinga
Aytu BioPharma Closes $16.6 Mln Offering To Support EXXUA Launch For Major Depressive Disorder
Jun 10 2025
NASDAQ.COM
Why Boot Barn Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
May 15 2025
Benzinga
AYTU BIOSCIENCE Earnings Results: $AYTU Reports Quarterly Earnings
May 15 2025
NASDAQ.COM
Show More News
